Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

This study has been completed.
Information provided by (Responsible Party):
Jesus Livio Jimenez Santos, Centro Universitario contra el Cáncer Identifier:
First received: January 18, 2014
Last updated: January 26, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)